Research articleProliferating and differentiating effects of three different growth factors on pluripotent mesenchymal cells and osteoblast like cellsBritt Wildemann1,2 , Nicole Burkhardt1 , Marc Luebberstedt1 , Thomas Vordemvenne3 and Gerhard Schmidmaier1,2  1
Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Germany 2
Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany 3
Dept. Trauma, Hand and Reconstructive Surgery, University Hospital, Muenster, Germany author email corresponding author email
Journal of Orthopaedic Surgery and Research 2007,
2:27doi:10.1186/1749-799X-2-27
|
| Published: |
20 December 2007 |
Abstract
Growth factors are in clinical use to stimulate bone growth and regeneration. BMP-2 is used in long bone and spinal surgery, PDGFbb for the treatment of periodontal defects and children with growth hormone receptor deficiency are treated with IGF-I.
Aim of the present study was the comparative analysis of the effect of these growth factors released from a local drug delivery system on cells of the osteogenic lineage at differing differentiation stages.
The experiments with the mesenchymal cell line C2C12 revealed a proliferating effect of all three growth factors and a differentiating effect of BMP-2 with a dramatic increase in alkaline phosphatase activity. None of the growth factors stimulated cell migration.
Human osteoblast like cells showed similar results with an increase in proliferation after stimulation with IGF-I or PDGFbb. The enzymatic activity of alkaline phosphatase was enhanced only in the cells stimulated with BMP-2. This group showed also more mineralized matrix compared to the other groups.
In conclusion, the growth factors IGF-I and PDGFbb delivered with a local drug delivery system stimulated cell proliferation, whereas BMP-2 showed a dramatic effect on differentiation on osteoblast precursor cells and osteoblast like cells. |